Butylated Hydroxytoluene vs Butylated Hydroxyanisole: which is worse?

What is Butylated Hydroxytoluene?

Butylated hydroxytoluene (BHT) is a synthetic lipophilic phenolic antioxidant preservative derived from petroleum. It is a white crystalline solid with chemical formula C15H24O. Like BHA, it prevents fat oxidation and is widely used in food, cosmetics, pharmaceuticals, jet fuel, and rubber.

What is Butylated Hydroxyanisole?

Butylated hydroxyanisole (BHA) is a synthetic phenolic antioxidant preservative derived from petroleum (see also bha entry). It is a mixture of 2-BHA and 3-BHA isomers, used to prevent oxidative rancidity in fats, oils, and fat-containing foods. Chemical formula C11H16O2.

Documented risks

Butylated Hydroxytoluene: BHT's carcinogenicity profile is complex and bidirectional. Some NTP bioassays found liver tumors in female mice at high doses, while other studies suggested BHT might inhibit tumor initiation in certain contexts. A 1986 NTP bioassay found liver tumors in female mice but anti-carcinogenic effects in the rat forestomach — making BHT's net carcinogenicity uncertain. IARC has not formally classified BHT in a specific Group due to this conflicting evidence. The NTP notes that BHT's carcinogenicity data are complex. The 'Report on Carcinogens' does not currently list BHT, unlike BHA, but the NTP has noted inconclusive evidence. Potential endocrine disruption: a 2017 study in Environmental Science & Technology found BHT disrupted thyroid hormone levels in female rats. Multiple animal studies have demonstrated weak estrogenic effects. The American Academy of Pediatrics' 2018 policy statement on food additives mentioned BHT as a synthetic preservative warranting reduced childhood exposure. Kellogg's Frosted Flakes in the US contains BHT to preserve freshness; the European version uses mixed tocopherols (vitamin E) instead — a commercially meaningful difference demonstrating feasibility of substitution. Japan banned BHT for food use based on its precautionary approach. The EU restricts it with ADI-based maximum permitted levels.

Butylated Hydroxyanisole: IARC classifies BHA as Group 2B (possible human carcinogen) based on forestomach tumor studies in rodents at high doses. The NTP lists it as 'reasonably anticipated to be a human carcinogen.' EFSA's 2012 review found endocrine-disrupting potential. Japan banned it for food use. The FDA permits it at 0.02% of fat content. Concerns about estrogen-receptor interaction have been documented in animal studies. Contact dermatitis from cosmetic use is reported.